Strong Upfront Engineering Approach Decreases Time-to-Market & Capital Costs
A mid-size, market leading orthopedics company working in the “Memory Metal” field was acquired by a Fortune 50 Medical Device Company. The product line that they had introduced was injection molded using prototype molds without any validated molding processes. This approach produced extremely high scrap rates and a continuous need to replace the prototype molds. Several suppliers were approached as potential partners, each one asked to develop a long-term strategy for the program.
View More